McDonald, K. L. And SEVİM NALKIRAN, H. 2013. Improved Responsiveness to Temozolomide by Blocking MIF Expression in Glioblastoma. Worldwide Innovative Networking in Personalized Cancer Medicine WIN 2013 Symposium-Personal Cancer Medicine: From Innovation to implementation , (Paris, France), 7.

McDonald, K. L., & SEVİM NALKIRAN, H., (2013). Improved Responsiveness to Temozolomide by Blocking MIF Expression in Glioblastoma . Worldwide Innovative Networking in Personalized Cancer Medicine WIN 2013 Symposium-Personal Cancer Medicine: From Innovation to implementation (pp.7). Paris, France

McDonald, Kerrie, And HATİCE SEVİM NALKIRAN. "Improved Responsiveness to Temozolomide by Blocking MIF Expression in Glioblastoma," Worldwide Innovative Networking in Personalized Cancer Medicine WIN 2013 Symposium-Personal Cancer Medicine: From Innovation to implementation, Paris, France, 2013

McDonald, Kerrie L. And SEVİM NALKIRAN, HATİCE S. . "Improved Responsiveness to Temozolomide by Blocking MIF Expression in Glioblastoma." Worldwide Innovative Networking in Personalized Cancer Medicine WIN 2013 Symposium-Personal Cancer Medicine: From Innovation to implementation , Paris, France, pp.7, 2013

McDonald, K. L. And SEVİM NALKIRAN, H. (2013) . "Improved Responsiveness to Temozolomide by Blocking MIF Expression in Glioblastoma." Worldwide Innovative Networking in Personalized Cancer Medicine WIN 2013 Symposium-Personal Cancer Medicine: From Innovation to implementation , Paris, France, p.7.

@conferencepaper{conferencepaper, author={Kerrie Leanne McDonald And author={HATİCE SEVİM NALKIRAN}, title={Improved Responsiveness to Temozolomide by Blocking MIF Expression in Glioblastoma}, congress name={Worldwide Innovative Networking in Personalized Cancer Medicine WIN 2013 Symposium-Personal Cancer Medicine: From Innovation to implementation}, city={Paris}, country={France}, year={2013}, pages={7} }